Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
August 29, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for January 20, 2007 Subscribe to this News Feed     Subscribe to this Podcast Feed  
 

Increasing Nicotine Levels Isn't the Only Chemical Trick Tobacco Companies Use to Addict New Smokers and to Keep Current Smokers Addicted

Harvard University researchers just confirmed findings from the state of Massachusetts that cigarette companies have increased nicotine levels in cigarettes by about 10-11% since 1997. Dr. Michael Rabinoff, a board certified psychiatrist on the faculty of the Department of Psychiatry at UCLA, expert on tobacco issues and author of Ending the Tobacco Holocaust :How Big Tobacco Affects our Health, Pocketbook, and PoliticalFreedom, and What We Can Do About It also points out that besides using increased nicotine levels to make cigarettes more addictive, tobacco companies use product engineering and many other chemical tricks to increase the addictive properties of cigarettes.

(PRWEB) January 20, 2007 -- Harvard University researchers just confirmed findings from the state of Massachusetts that cigarette companies have increased nicotine levels in cigarettes by about 10-11% since 1997.

Dr. Michael Rabinoff, a board certified psychiatrist on the faculty of the Department of Psychiatry at UCLA, expert on tobacco issues and author of Ending the Tobacco Holocaust: How Big Tobacco Affects Our Health, Pocketbook, and Political Freedom, and What We Can Do About It, also points out that "besides using increased nicotine levels to make cigarettes more addictive, tobacco companies use product engineering and many other chemical tricks to increase the addictive properties of cigarettes".

besides using increased nicotine levels to make cigarettes more addictive, tobacco companies use product engineering and many other chemical tricks to increase the addictive properties of cigarettes
Dr. Rabinoff discusses many of the other chemical tricks that Big Tobacco uses to addict smokers in his new book Ending The Tobacco Holocaust (http://www.TobaccoBook.com). Some of those chemical tricks include:

Ammonia technology. Ammonia generating formulas, such as the combination of diammonium hydroxide, pectin, and ammonium hydroxide increase nicotine transfer from tobacco into smoke. Ammonia technology, reconstituted tobacco, and tobacco essence are utilized to increase freebase nicotine, and to have front-end lift (where cigarettes are engineered to have the highest level of nicotine in the first puffs). Increased free base nicotine may lead to increased distribution, faster distribution of nicotine in lungs, faster crossing of membranes, faster central nervous system penetration, and greater concentration crossing membranes at lungs and central nervous system. All of this can lead to increased impact and addictive effect.

Anesthetics such as menthol, benzaldehyde, benzoic acid, benzyl alcohol, carvacrol, cinnamaldehyde, cinnamic acid, guaiacol, linalnyl acetate, and thymol have a numbing effect on the respiratory tract, masking irritation from cigarette smoke. According to a report in the medical journal Chest, 76% of black smokers choose menthol brands compared to 23% of white smokers. The menthol brands are associated with higher levels of nicotine and carbon monoxide, and appear to be associated with increased health risks as compared to nonmenthol brands.

Bronchodilators such as cocoa, glycyrrhizin (a component of licorice), and caffeine open the airways and allow the smoke to be drawn more deeply into the lungs.

Levulinic acid binds to nicotine receptors in the brain, and increases the brain's response to nicotine.

Sugars are extensively added to cigarettes, especially "reducing sugars" used for the ammonia technology processes that increase vapor freebase nicotine. In fact, a 1990 Brown & William study found that 11.2-12.9% of Marlboro cigarettes were sugars. (Some of the sugars in tobacco are natural, but tobacco companies also add significant amounts of sugars).

According to Victor DeNoble, a former scientist at Phillip Morris, industry scientists suspected that acetaldehyde, produced by burning sugars, could enhance the addictive effects of tobacco. In the early 1980s, he used rats in researching the behavioral effects of acetaldehyde or nicotine alone, and of acetaldehyde combined with nicotine. He found that the product of acetaldehyde and dopamine was highly addictive, providing evidence that a compound in cigarettes other than nicotine could lead to addiction. (He observed that rats will repeatedly press a bar to obtain acetaldehyde). Furthermore, the experiments of Philip Morris (PM) scientists found that the addictive effect of acetaldehyde is "synergistic" with nicotine's addictive effect, so that the addictive effect of the two compounds when combined together is greater than the sum of each compound's addictive effect.

You can read more about the many chemical tricks the tobacco companies use to addict and keep smokers addicted in Chapter 4 of Ending The Tobacco Holocaust (http://www.TobaccoBook.com)

The author of Ending the Tobacco Holocaust, Michael Rabinoff D.O. Ph.D., (Elite Books, November 2006, hardcover, $24.95, ISBN 1-60070-012-8, available at local bookstores, Amazon, Borders, Barnes and Noble) is a psychiatrist with many public presentations to his credit. He has a driving passion to get the message of the book to a wide audience, and the ability to engage experienced professionals to assist him towards that goal. More information about the book, and additional free information, can be found at http://www.TobaccoBook.com.

Michael Rabinoff, D.O., Ph.D., is a board-certified psychiatrist on the research faculty of the UCLA Department of Psychiatry and is also a Senior Partner in the Kaiser Permanente Medical Group. In addition, he is the C.E.O. and President of Biogenesys, Inc., a biomedical research and development corporation. He has spent over a decade researching and writing about the devastating effects of tobacco on our health, economy and nation's politics. An esteemed psychiatrist and holder of two patents, Rabinoff has been quoted in the Wall Street Journal and Business Week, has published in the New England Journal of Medicine and other top-flight medical journals, and presented his findings on tobacco addiction and industry profiteers to the American Public Health Association and the World Congress on Tobacco or Health.

Media Contact: Josh Tyree 503-652-5216

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/SGFsZi1TcXVhLVN1bW0tTG92ZS1NYWduLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download Podcast MP3
Download Podcast iTunes
Download Podcast OGG
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Joshua Tyree
Biogenesys, Inc.
503-652-5216
Email us Here
ATTACHED FILES

Ending The Tobacco Holocaust book
book cover

Dr. Michael Rabinoff
author photo

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright